These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 32191459)
21. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities. Bottemanne P; Muccioli GG; Alhouayek M Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427 [TBL] [Abstract][Full Text] [Related]
22. Molecular mechanism of activation of the immunoregulatory amidase NAAA. Gorelik A; Gebai A; Illes K; Piomelli D; Nagar B Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10032-E10040. PubMed ID: 30301806 [TBL] [Abstract][Full Text] [Related]
23. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α. Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614 [TBL] [Abstract][Full Text] [Related]
24. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation. Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589 [TBL] [Abstract][Full Text] [Related]
25. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives. Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121 [TBL] [Abstract][Full Text] [Related]
26. Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory. Zhou L; Tian M; Zhang B; Cao X; Huo X; Yang F; Cao P; Feng L; Ma X; Tian X Int J Biol Macromol; 2024 Apr; 263(Pt 2):130307. PubMed ID: 38382784 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors. Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897 [TBL] [Abstract][Full Text] [Related]
31. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice. Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639 [TBL] [Abstract][Full Text] [Related]
32. Activity-Based Probe for N-Acylethanolamine Acid Amidase. Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511 [TBL] [Abstract][Full Text] [Related]
33. Ramulus Cinnamomi essential oil exerts an anti-inflammatory effect on RAW264.7 cells through N-acylethanolamine acid amidase inhibition. Jia W; He X; Jin W; Gu J; Yu S; He J; Yi Z; Cai B; Gao H; Yang L J Ethnopharmacol; 2023 Dec; 317():116747. PubMed ID: 37311500 [TBL] [Abstract][Full Text] [Related]
34. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis. Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582 [TBL] [Abstract][Full Text] [Related]
35. Insights in the mechanism of action and inhibition of N-acylethanolamine acid amidase by means of computational methods. Lodola A; Rivara S; Mor M Adv Protein Chem Struct Biol; 2014; 96():219-34. PubMed ID: 25443959 [TBL] [Abstract][Full Text] [Related]
36. The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis. Sasso O; Summa M; Armirotti A; Pontis S; De Mei C; Piomelli D J Invest Dermatol; 2018 Mar; 138(3):562-569. PubMed ID: 29054595 [TBL] [Abstract][Full Text] [Related]
37. Inhibiting immunoregulatory amidase NAAA blocks ZIKV maturation in Human Neural Stem Cells. Lai M; La Rocca V; Iacono E; Filipponi C; De Carli A; Favaro D; Fonnesu R; Filippini F; Spezia PG; Amato R; Catelli E; Matteo B; Lottini G; Onorati M; Clementi N; Freer G; Piomelli D; Pistello M Antiviral Res; 2023 Aug; 216():105664. PubMed ID: 37414288 [TBL] [Abstract][Full Text] [Related]
38. Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism. Palese F; Pontis S; Realini N; Torrens A; Ahmed F; Assogna F; Pellicano C; Bossù P; Spalletta G; Green K; Piomelli D Pharmacol Res; 2022 Aug; 182():106338. PubMed ID: 35781057 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors. Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]